البلد: أيرلندا
اللغة: الإنجليزية
المصدر: HPRA (Health Products Regulatory Authority)
Valsartan
Actavis Group PTC ehf
C09CA; C09CA03
Valsartan
40 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
Angiotensin II antagonists, plain; valsartan
Marketed
2009-01-30
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT VALSARTAN ACTAVIS 40 MG FILM-COATED TABLETS Valsartan READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Valsartan Actavis is and what it is used for 2. What you need to know before you take Valsartan Actavis 3. How to take Valsartan Actavis 4. Possible side effects 5. How to store Valsartan Actavis 6. Contents of the pack and other information 1. WHAT VALSARTAN ACTAVIS IS AND WHAT IT IS USED FOR Valsartan Actavis belongs to a class of medicines known as angiotensin II receptor antagonist, which help to control high blood pressure. Angiotensin II is a substance in the body that causes vessels to tighten, thus causing your blood pressure to increase. Valsartan Actavis works by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure is lowered. Valsartan Actavis 40 mg film-coated tablets CAN BE USED FOR THREE DIFFERENT CONDITIONS: • TO TREAT HIGH BLOOD PRESSURE IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE. High blood pressure increases the workload on the heart and arteries. If not treated it can damage the blood vessels of the brain, heart, and kidneys, and may result in a stroke, heart failure, or kidney failure. High blood pressure increases the risk of heart attacks. Lowering your blood pressure to normal reduces the risk of developing these disorders. • TO TREAT ADULT PATIENTS AFTER A RECENT HEART ATTACK (myocardial infarction). “Recent” here means between 12 hours and 10 days. • TO TREAT SYMP اقرأ الوثيقة كاملة
HealthProductsRegulatoryAuthority 07May2019 CRN008Y57 Page1of14 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Valsartan40mgfilm-coatedtablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Onefilm-coatedtabletcontains40mgofvalsartan Excipients with known effect: Each Valsartan40mgfilm-coatedtabletcontains21.11mglactosemonohydrateand0.126mglecithin(containssoyaoil) For thefulllistofexcipients,seesection6.1. 3 PHARMACEUTICAL FORM Film-coatedtablet Valsartan40mgtablets:Yellow,oval,biconvex,film-coatedtablets,9x4.5mm,withascorelineononesideandmarkedwitha Vontheother. Thetabletcanbedividedintoequaldoses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypertension Treatmentofhypertensioninchildrenandadolescents6to18 yearsofage. Recent myocardial infarction Treatmentofclinicallystableadultpatientswithsymptomaticheartfailureorasymptomaticleftventricularsystolicdysfunction afterarecent(12 hours-to10 days)myocardialinfarction(seesections4.4and5.1). Heart failure TreatmentofadultpatientswithsymptomaticheartfailurewhenACE‑inhibitorsarenottoleratedorinbeta‑blockerintolerant patientsasadd‑ontherapytoACE‑inhibitorswhenmineralcorticoidreceptorantagonistcannotbeused(seesections4.2,4.4, 4.5and5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology_ Recent myocardial infarction Inclinicallystablepatients,therapymaybeinitiatedasearlyas12 hoursafteramyocardialinfarction.Afteraninitialdoseof 20 mgtwicedaily,valsartanshouldbetitratedto40 mg,80 mg,and160 mgtwicedailyo اقرأ الوثيقة كاملة